Popular
BlogNEW
CompaniesNEW
Finance
Technology
Banking
Information Technology
Oil and Energy
Internet
Mining and Metals
Communications
Real Estate
Biotechnology
Automotive
Medical
Retail
Energy
Ultragenyx Analyst Day Presentation slide image

Ultragenyx Analyst Day Presentation

EVKEEZA® Exclusivity summary Europe Data & Marketing Exclusivity 2031 Evkeeza Ab Patent 2036* EvkeezaⓇ (evinacumab-dgnb) Injection 2022 2024 2026 2028 2030 2032 2034 2036 2038 2040 *Includes projected EU SPC award 25 Confidential and Proprietary Exemplary additional patent applications pending: • Evkeeza w/ PCSK9 Ab • Evkeeza w/ statins . Evkeeza formulations Projected expiration dates between 2037-2041 ultragenyx
View entire presentation

Product

HomeSearchAccount

Categories

Finance PresentationsTechnology PresentationsBanking PresentationsInformation Technology PresentationsOil and Energy PresentationsInternet PresentationsMining and Metals PresentationsCommunications PresentationsReal Estate PresentationsBiotechnology PresentationsAutomotive PresentationsMedical PresentationsRetail PresentationsEnergy Presentations

Company

InsightsContactSupport

Legal

Terms of ServicePrivacy Policy

Connect

TwitterLinkedInInstagramYouTube